Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
A review of avelumab in locally advanced and metastatic bladder cancer
Arpit Rao
,
Manish R Patel
Medicine - Hematology, Oncology, Transplant
Genetics Mechanisms of Cancer
Research output
:
Contribution to journal
›
Review article
›
peer-review
21
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A review of avelumab in locally advanced and metastatic bladder cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Avelumab
100%
Metastatic Bladder Cancer
100%
Locally Advanced Bladder Cancer
100%
Cell Death
50%
First-line Chemotherapy
25%
Poor Prognosis
25%
Bladder Cancer
25%
Clinical Development
25%
Pharmacology
25%
Metastatic Urothelial Cancer
25%
Metastatic Disease
25%
Anti-PD-L1 Antibody
25%
Urothelial Carcinoma
25%
Patient Survival
25%
Clinical Experience
25%
Recurrent Metastatic
25%
Immune Therapy
25%
Urothelial Cancer
25%
Death Ligands
25%
Bacillus Calmette
25%
Accelerated Approval
25%
Metastatic Urothelial Carcinoma
25%
Immune Checkpoint Blockade
25%
Immune Checkpoint Inhibitors
25%
United States Food
25%
Medicine and Dentistry
Metastatic Bladder Cancer
100%
Avelumab
100%
Transitional Cell Carcinoma
50%
Urothelial Cancer
50%
Cell Death
50%
Programmed Death-Ligand 1
25%
Metastatic Carcinoma
25%
Bladder Cancer
25%
First-Line Chemotherapy
25%
Immune Checkpoint Inhibitor
25%
Immune Checkpoint Blockade
25%
Immunotherapy
25%
Diseases
25%